Record citatie

APA (7e ed.) Bronvermelding
Rouach, V., Goldshtein, I., Wolf, I., Catane, R., Chodick, G., Iton, A., . . . Cohen, D. (2018). Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer. Elsevier.
Chicago (17e ed.) Bronvermelding
Rouach, Vanessa, Inbal Goldshtein, Ido Wolf, Raphael Catane, Gabriel Chodick, Amit Iton, Naftali Stern, en Daniel Cohen. Exposure to Alendronate Is Associated with a Lower Risk of Bone Metastases in Osteoporotic Women with Early Breast Cancer. Elsevier, 2018.
MLA (9e ed.) Bronvermelding
Rouach, Vanessa, et al. Exposure to Alendronate Is Associated with a Lower Risk of Bone Metastases in Osteoporotic Women with Early Breast Cancer. Elsevier, 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.